Sector consensus Gan & Lee Pharmaceuticals.

Equities

End-of-day quote Shanghai S.E. Other stock markets 12/09/2024			5-day change	1st Jan Change
38.57 ^CNY	-1.08%		-3.82%	-26.74%

09-06	Gan & Lee Pharmaceuticals. announces an Equity Buyback for CNY 300 million worth of its shares.	CI
09-05	Gan & Lee Pharmaceuticals. authorizes a Buyback Plan.	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m Revision of opinion	Average Target P.	Ecart obj. / dr	Nbr of analysts
GAN & LEE PHARMACEUTICALS.	-	62.00	+59.02%	2
CSL LIMITED		210.16	+5.46%	15
SAMSUNG BIOLOGICS CO.,LTD.		1,061,992.00	+8.26%	25
UCB		164.00	+1.77%	19
BIOGEN INC.		271.42	+36.33%	30
BIOMARIN PHARMACEUTICAL INC.		111.62	+31.65%	25
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.		62.70	-8.97%	2
INCYTE CORPORATION		74.17	+17.49%	21
ALTEOGEN INC.		271,666.67	-11.22%	3
SWEDISH ORPHAN BIOVITRUM AB		328.91	+3.24%	11
INNOVENT BIOLOGICS, INC.		53.01	+34.09%	27
INTRA-CELLULAR THERAPIES, INC.		96.13	+28.66%	15
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.		38.55	+80.20%	8
GRIFOLS, S.A.		17.72	+80.67%	15
BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.		29.92	+28.65%	4
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	-	6.550	-3.82%	2
BRIDGEBIO PHARMA, INC.		48.07	+71.75%	14
AVIDITY BIOSCIENCES, INC.		66.80	+64.78%	10
APELLIS PHARMACEUTICALS, INC.		69.82	+82.02%	17
AXSOME THERAPEUTICS, INC.		125.24	+37.58%	17
Average		66,774.77	+32.38%	14
Weighted average by Cap.		172,311.12	+17.13%	17